Minimally invasive treatments in Greenlawn, New York

Welcome to the practice of Dr. Ashutosh (Ash) K. Tewari, MBBS, MCh, FRCS (Hon), located at 5 Cuba Hill Road, Greenlawn, New York. Dr. Tewari is a distinguished urologist and prostate cancer specialist, currently serving as the Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. With an impressive career, Dr. Tewari has performed over 5,000 robotic radical prostatectomy surgeries, making his case series one of the largest globally and establishing his outcomes as the gold standard in the field. Dr. Tewari is dedicated to advancing prostate cancer treatment through his leadership at the Tewari Lab, where groundbreaking research into the genomic causes of prostate cancer is underway. His work translates genomic insights into practical applications for physicians, leveraging advanced imaging techniques. Recognized for his contributions, Dr. Tewari received the prestigious American Urological Association’s Gold Cystoscope Award in 2012.

Welcome to the practice of Michael Gorin, MD, where exceptional urologic care meets cutting-edge research and innovation. Conveniently located at 5 Cuba Hill Road, Greenlawn, New York, Dr. Gorin is a highly esteemed Associate Professor in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. He specializes in treating a wide range of urologic conditions, including enlarged prostate symptoms, kidney stones, kidney tumors, and prostate cancer. As a fellowship-trained endourologist, Dr. Gorin offers the most advanced minimally invasive treatment options to his patients. Dr. Gorin is not only a skilled surgeon but also a pioneering clinical researcher. He is renowned for his work in molecular imaging for diagnosing and managing urologic malignancies. Notably, he was part of the first clinical team to explore PSMA-targeted PET imaging with PYLARIFY, leading to its FDA approval. This breakthrough imaging technique has since benefited countless prostate cancer patients.